Clinical Study to Generate a Set of Data Characterising Clinical Events, Physiological Responses, and Innate and Adaptive Immune Responses Following a Single IM Immunisation With Boostrix® or Placebo in Healthy Adults
Phase of Trial: Phase IV
Latest Information Update: 13 Aug 2016
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Bordetella infections
- Focus Adverse reactions
- Acronyms BioVacSafe - Boostrix
- 13 Aug 2016 New source identified and integrated (European Clinical Trials Database; EudraCT2015-002879-14).
- 11 Aug 2016 Status changed from active, no longer recruiting to completed.
- 16 Dec 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.